A Case of Castration-Resistant Prostate Cancer with Fatal Convulsive Seizure after Administration of Enzalutamide 
    
    
              
              Enzalutamide, an androgen receptor antagonist, is a standard drug for the treatment of castrationresistant prostate cancer. A 77-year-old man developed a seizure after administration of enzalutamide. The patient presented with general fatigue and high fever approximately 5 weeks after oral administr...
              Ausführliche Beschreibung
          
    
                  
        Bibliographische Detailangaben
                  | Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 63(2017), 10 vom: 05. Okt., Seite 431-433 
 | 
|---|
                  | 1. Verfasser: | Iwanishi, Toshichika
      (VerfasserIn) | 
|---|
                  | Weitere Verfasser: | Yumiba, Satoru, 
      
        Koida, Youhei, 
      
        Kobayashi, Masao, 
      
        Komori, Kazuhiko, 
      
        Ono, Yutaka | 
|---|
                  | Format: | Online-Aufsatz | 
|---|
                  | Sprache: | Japanese | 
|---|
                  | Veröffentlicht: | 2017 
 | 
|---|
                  | Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica 
 | 
|---|
                  | Schlagworte: | Case Reports
            Journal Article
            Review
            Prostate cancer
            Seizure
            Benzamides
            Nitriles
            Phenylthiohydantoin
            2010-15-3
            enzalutamide
            93T0T9GKNU | 
|---|